Now live: Pro — the full 13F research suite for serious investorsSee pricing →
JGP Global Gestao de Recursos Ltda.

Q4 2024 · 13F-HR

JGP Global Gestao de Recursos Ltda.holdings as filed

Filed 2025-01-24 · accession 0001536562-25-000002

$43.9M
Reported value
40
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
644535106NGDNNEW GOLD INC$16.1M36.7%6,500,000CommonSOLE
G85158106STNESTONECO LTD-A$6.1M13.9%764,797CommonSOLE
532457108LLYELI LILLY & CO$1.8M4.19%2,387CommonSOLE
07725L102ONCBEIGENE LTD-ADR$1.7M3.94%9,374CommonSOLE
45337C102INCYINCYTE CORP$1.7M3.87%24,633CommonSOLE
46120E602ISRGINTUITIVE SURGICAL INC$1.5M3.34%2,810CommonSOLE
879273209TEOTELECOM ARGENTINA SA-SP ADR$852,9851.94%67,751CommonSOLE
05961W105BMABANCO MACRO SA-ADR$833,7811.90%8,617CommonSOLE
399909100GGALGRUPO FINANCIERO GALICIA-ADR$819,5081.87%13,150CommonSOLE
984245100YPFYPF S.A.-SPONSORED ADR$816,6171.86%19,210CommonSOLE
54150E104LOMALOMA NEGRA CIA IND-SPON ADR$785,4851.79%65,786CommonSOLE
883556102TMOTHERMO FISHER SCIENTIFIC INC$739,7671.68%1,422CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$698,0871.59%1,380CommonSOLE
863667101SYKSTRYKER CORP$670,4131.53%1,862CommonSOLE
004225108ACADACADIA PHARMACEUTICALS INC$635,2771.45%34,620CommonSOLE
04016X101ARGXARGENX SE - ADR$616,2301.40%1,002CommonSOLE
558868105MDGLMADRIGAL PHARMACEUTICALS INC$614,9801.40%1,993CommonSOLE
235851102DHRDANAHER CORP$567,4481.29%2,472CommonSOLE
58933Y105MRKMERCK & CO. INC.$566,5391.29%5,695CommonSOLE
008474108AEMAGNICO-EAGLE MINES LTD$508,1301.16%6,497CommonSOLE
036752103ELVELEVANCE HEALTH INC$452,2711.03%1,226CommonSOLE
457669307INSMINSMED INC$422,5250.96%6,120CommonSOLE
92532F100VRTXVERTEX PHARMACEUTICALS INC$389,8140.89%968CommonSOLE
75886F107REGNREGENERON PHARMACEUTICALS$383,2340.87%538CommonSOLE
046353108AZNNASTRAZENECA PLC-SPONS ADR$377,5260.86%5,762CommonSOLE
02043Q107ALNYALNYLAM PHARMACEUTICALS INC$363,7890.83%1,546CommonSOLE
031162100AMGNAMGEN INC$354,7310.81%1,361CommonSOLE
76155X100RVMDREVOLUTION MEDICINES INC$336,9730.77%7,704CommonSOLE
101137107BSXBOSTON SCIENTIFIC CORP$321,9990.73%3,605CommonSOLE
86627T108SMMTSUMMIT THERAPEUTICS INC$304,7930.69%17,080CommonSOLE
76243J105RYTMRHYTHM PHARMACEUTICALS INC$301,0600.69%5,378CommonSOLE
011532108AGIALAMOS GOLD INC-CLASS A$284,9350.65%15,452CommonSOLE
125523100CICIGNA CORP$251,5640.57%911CommonSOLE
501575104KYMRKYMERA THERAPEUTICS INC$241,0180.55%5,991CommonSOLE
70975L107PENPENUMBRA INC$213,9690.49%901CommonSOLE
50015M109KODKODIAK SCIENCES INC$128,8530.29%12,950CommonSOLE
00288U106ABCLABCELLERA BIOLOGICS INC$66,2120.15%22,598CommonSOLE
826599102SGMLSIGMA LITHIUM CORP$25,0000.06%5,000PUTSOLE
157085101CERSCERUS CORP$24,5830.06%15,963CommonSOLE
670851500OI SA-ADR$13,0780.03%50,301CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.